Imipramine is a tricyclic antidepressant of the dibenzazepine class, indicated for the treatment of major depressive disorder, enuresis, and certain anxiety disorders. By inhibiting the neuronal reuptake… Read more

![Chemical structure of 10-[3-(Dimethylamino)propyl]acridan Hydrochloride-d6 (Impurity)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2733001-11-9-10-3-Dimethylaminopropylacridan-Hydrochloride-d6-Impurity.png&w=3840&q=75)





![Chemical structure of 3,7-Dichloro-10,11-dihydro-5H-dibenzo[b,f]azepine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F13080-74-5-37-Dichloro-1011-dihydro-5H-dibenzobfazepine.png&w=3840&q=75)
![Chemical structure of 5-(3-(Dimethylamino)propyl)-10,11-dihydro-5H-dibenzo[b,f]azepin-10-ol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F796-28-1-5-3-Dimethylaminopropyl-1011-dihydro-5H-dibenzobfazepin-10-ol.png&w=3840&q=75)
















Imipramine is a tricyclic antidepressant of the dibenzazepine class, indicated for the treatment of major depressive disorder, enuresis, and certain anxiety disorders. By inhibiting the neuronal reuptake of serotonin and norepinephrine, it modulates neurotransmitter levels in the synaptic cleft. This category features a comprehensive range of Imipramine reference standards, metabolites, and degradation products necessary for robust quality control and regulatory compliance. Analytical laboratories utilize these high-quality compounds for precise impurity profiling and the identification of synthetic intermediates or degradation products that may emerge during manufacturing and storage. Additionally, stable isotope labelled versions of Imipramine are essential for accurate quantitative analysis and method validation, providing internal standards to account for matrix effects in complex biological or pharmaceutical samples. These standards ensure that analytical procedures consistently meet established pharmacopeial and safety specifications.